-
TIME
Sunday, January 12, 2025
-
08:00 – 09:00
Registration
-
09:00 – 09:15
Opening Remark – State of Healthcare Investment
Speaker:
David Chen, Managing Director, BFC Group
-
09:15 – 10:15
Faith to Incubate: Global Biotech Investment Trends and Focus
Moderator:
Seamus Jiang, U.S./China Cross-border Deals Leader, Managing Director, PwC
Panelist:
Tony Liu, Chairman and CEO, AbelZeta Pharma
Frank Nestle, Partner and CEO of 3DC, Deerfield
Ricky Sun, Partner, Bain Capital
JeffZhou, Executive Director, J.P. Morgan
Fang Ming, Managing Director, Redmile Group
-
10:15 – 11:15
Big Pharma, Big Synergy: Harnessing the Power of Strategic Collaborations
Moderator:
Thijs Spoor,Chief Executive Officer,Perspective Therapeutics
Panelist:
Rene Fuertig, Global Head CNS BD&L, Boehringer Ingelheim
Marcel Reichen, Head of Search & Evaluation Radioligand Therapies at Corporate & Business Development, Novartis
Matthieu Merlin, Head of Business Development General Medicines GBU, Sanofi
Johan Verbeeck, Vice President Business Development, Oncology, Johnson & Johnson Innovative Medicine
Dominic McDonald, Executive Director, Search & Evaluation & Oncology, GSK
-
11:15 – 11:45
Coffee Break
-
11:45 – 12:45
Navigating the Complexities of Cross-Border Licensing in a Globalized Market
Moderator:
Lila Hope, Partner, Cooley
Panelist:
Marya Postner, Partner, Cooley
Maha Radhakrishnan, Executive Partner, Sofinnova Investmentss
Ying Wang Schmidt, Senior Director, Business Development Project Leader, Roche
Kevin Penghui Chen, Founding Partner, BioTrack Capita
-
12:45 – 14:00
Lunch Reception
-
14:00 – 17:00
Company Road Show
-
17:00 – 18:00
Emerging Licensing Trends: The Impact of Game-Changing NewCos
Moderator:
Patrick Loofbourrow, Partner, Cooley
Panelist:
Andrew Lam, Managing Director, Head of Biotech Private Equity, Allybridge
Cory Freedland, Partner, Samsara Biocapital
Shaan Gandhi, Vice President and Head of Strategic Partnerships, Pfizer Ignite
Birgit Reitmaier, Executive Director, Head of BD Asia Pacific, Merck KGaA, Darmstadt, Germany
Jeff Zechnich, PwC, Partner